A scheduled second endoscopy 16 to 24 hours after initial endoscopic hemostasis reduced recurrent peptic ulcer bleeding

January 2004
ACP Journal Club;Jan/Feb2004, Vol. 140 Issue 1, p11
Academic Journal
This article focuses on a study regarding the effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding, published in the 2003 issue of the journal "Gut." For this study 194 patients who were 15 to 90 years of age and had an endoscopically confirmed bleeding peptic ulcer with stigmata of acute bleeding were studied. After successful endoscopic hemostasis, patients were allocated to a scheduled second endoscopy 16 to 24 hours after initial endoscopy or to a control group. At 7 and 30 days after initial endoscopic hemostasis, fewer patients developed recurrent bleeding in the scheduled second endoscopy group than in the control group.


Related Articles

  • A scheduled second endoscopy 16 to 24 hours after initial endoscopic hemostasis reduced recurrent peptic ulcer bleeding: COMMENTARY. Howden, Colin W. // ACP Journal Club;Jan/Feb2004, Vol. 140 Issue 1, p11 

    This article focuses on a study regarding the effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding, published in the 2003 issue of the journal "Gut." In the author's opinion, only a few patients with ulcer bleeding might benefit from a planned second therapeutic endoscopy....

  • Long-term Follow-up of Endoscopic Treatment for Bleeding Gastric and Duodenal Ulcers. Inadomi, John; Koch, Johannes; Cello, John P. // American Journal of Gastroenterology;Jul1995, Vol. 90 Issue 7, p1065 

    Objective: To examine the long-term consequences of endoscopic therapy for bleeding peptic ulcers. Methods: Eighty-seven consecutive patients who underwent endoscopic treatment for bleeding gastric ulcer (GU) and/or duodenal ulcer (DU) over a 42-month period were identified. Long-term follow-up...

  • Seasonal Pattern in the Incidence of Bleeding Caused by Peptic Ulcer in Israel. Bendahan, J.; Gilboa, S.; Paran, H.; Neufeld, D.; Pomerantz, I.; Novis, B.; Freund, U. // American Journal of Gastroenterology;Jun1992, Vol. 87 Issue 6, p733 

    We have reviewed all endoscopies performed in our hospital between 1977 and 1986. Daring that period, 1337 endoscopies were performed to identify bleeding from peptic ulcers. Excluded were cases in which a predisposing factor was found, such as the use of ulcerogenic drugs. Also excluded were...

  • Failures of Endoscopic Therapy for Bleeding Peptic Ulcer: An Analysis of Risk Factors. Choudari, C. P.; Rajgopal, C.; Elton, R. A.; Palmer, K. R. // American Journal of Gastroenterology;Nov1994, Vol. 89 Issue 11, p1968 

    Objectives: The role of therapeutic endoscopy in bleeding peptic ulcer is well documented. Nevertheless, failures of endoscopic therapy occur, and such patients could be put at an increased risk of death by delays in definitive surgery. The aim of this study was to define factors associated with...

  • Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial. Chiu P W Y; Lam C Y W; Lee S W; Kwong K H; Lam S H; Lee D T Y; Kwok S P Y // Gut;Oct2003, Vol. 52 Issue 10, p1403 

    Aim: Recurrent bleeding after initial haemostasis is an important factor that directly relates to the outcome in the management of peptic ulcer bleeding. Conflicting reports have been published concerning the effectiveness of scheduled second therapeutic endoscopy on ulcer rebleeding. We...

  • Management and outcome of patients undergoing surgery after acute upper gastrointestinal haemorrhage. Rockall, T. A. // Journal of the Royal Society of Medicine;Oct1998, Vol. 91 Issue 10, p518 

    Most patients with acute upper gastrointestinal haemorrhage are managed conservatively or with endoscopic intervention but some ultimately require surgery to arrest the haemorrhage. We have conducted a population-based multicentre prospective observational study of management and outcomes. This...

  • Risk Factors Associated with Rebleeding in Patients with High Risk Peptic Ulcer Bleeding: Focusing on the Role of Second Look Endoscopy. Kim, Sung; Lee, Si; Kim, Kyeong; Jang, Byung; Kim, Tae; Jeon, Seong; Kwon, Joong; Kim, Eun; Jung, Jin; Park, Kyung; Cho, Kwang; Kim, Hyun; Park, Chang; Park, Jeong; Yang, Chang; Kim, Sung Bum; Lee, Si Hyung; Kim, Kyeong Ok; Jang, Byung Ik; Kim, Tae Nyeun // Digestive Diseases & Sciences;Feb2016, Vol. 61 Issue 2, p517 

    Background: Re-bleeding after initial hemostasis in peptic ulcer bleeding can be life threatening. Identification of factors associated with re-bleeding is important. The aims of this study were to determine incidence of rebleeding in patients with high risk peptic ulcer bleeding...

  • Proton Pump Inhibitors After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding. Mesihovic, Rusmir; Vanis, Nenad; Mehmedovic, Amila; Gornjakovic, Srdjan; Gribajcevic, Mehmed // Medicinski Arhiv;2009, Vol. 63 Issue 6, p323 

    Background: Peptic ulcer bleeding is a common and potentially fatal condition. For patients with bleeding peptic ulcers that display major endoscopic stigmata of recent hemorrhage, a combination of endoscopic and pharmacologic therapy is the current standard management. Objective: To show our...

  • Continuous Infusion of Pantoprazole versus Ranitidine for Prevention of Ulcer Rebleeding: A U.S. Multicenter Randomized, Double-Blind Study. Jensen, Dennis M.; Pace, Samuel C.; Soffer, Elaine; Comer, Gail M. // American Journal of Gastroenterology;Sep2006, Vol. 101 Issue 9, p1991 

    OBJECTIVES: No North American randomized study has compared ulcer rebleeding rates after endoscopic hemostasis in high-risk patients treated with high-dose intravenous (IV) proton pump inhibitors (PPIs) or IV histamine-2 receptor antagonists. Our hypothesis was that ulcer rebleeding with IV...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics